The company Anebulo Pharmaceuticals (NASDAQ: ANEB) is investing in an antidote for cannabis intoxication. The social and medical issues associated with acute cannabis intoxication (ACI) are often underestimated, because of the perceived lack of risk of cannabis overdose.
Although cannabis use is considered relatively benign, there is an increasing appreciation of the risks of cannabis over consumption and its burden on the healthcare system. However, there has been less discussion of the risks associated with the simultaneous consumption of alcohol and cannabis.
The burden on the healthcare system from cannabis use is often underappreciated, because many see the risks of smoking marijuana as low. However, there are a very large number of visits to the emergency room every year as a result of cannabis intoxication.
A problem of increasing social importance is the rise in the use of synthetic cannabis alternatives, commonly called K2 or Spice or a number of other brand names.